TerminatedPhase 4

Changes in Macular Thickness After Patterns Scan Laser

Stopped: Undefined

Mexico8 participantsStarted 2007-10

Plain-language summary

Laser photocoagulation has become the treatment of choice in PDR. Laser photocoagulation has become the treatment of choice in TMD. The aim is to destroy a substantial portion of the peripheral retina in order to reduce the angiogenic stimulus (decrease the difference between oxygen demand and the administration). Their effectiveness is determined by the extent of destruction of the retina (2.4).

Who can participate

Age range25 Years – 95 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients older than 25 years, with a diagnosis of severe NPDR or PRD. * Good pupil mydriasis (minimum 5mm) With clear media * Patients without previous laser treatment or treatment with antiangiogenic drug. Exclusion Criteria: * Patients who do not accept informed consent. * Patients with clinical macular Edema before treatment. * Significant corneal opacity. * Patients with other eye diseases that interfere with the studies required for the monitoring of patients. * History of refractive surgery, glaucoma or ocular hypertension, intraocular inflammation, choroiditis multifocal, retinal detachment, optic neuropathy (4). * Patients with tractional retinal detachment due to abundant fibrovascular tissue. Or important fibrovascular tissue that fold or detach the retina.

What they're measuring

Retinal thickness after treatment

Timeframe: 12 weeks

Trial details

NCT IDNCT00563628

SponsorAsociación para Evitar la Ceguera en México

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2007-10

View on ClinicalTrials.gov More Non Proliferative Diabetic Retinopathy trials